Hybrid DBT for Veterans to Further Reduce PTSD and Emotion Regulation Problems
Official title: REfreshment of Dialectical Behaviour Therapy for Veterans to Further Reduce Symptoms and Prevent Relapse of Post-traumatic Stress Disorder and Emotion Regulation Symptoms by Guided Self-Help
Run by Arkin · NCT07652645 · Data updated 2026-11-12
This study tests a hybrid dialectical behavior therapy program for veterans with PTSD and emotion regulation issues to see if it helps reduce symptoms and improve daily functioning.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | Arkin Industry-sponsored |
| Locations | 1 site (Amstelveen, North Holland) |
| Status | Recruiting |
| Started | June 1, 2026 |
| Main results expected | September 2028 |
| Study ends | October 2028 |
| Registry record updated | June 17, 2026 |
| Trial ID | NCT07652645 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Dutch-speaking adult veterans (18+) treated at the Sinai Center, with war-related PTSD, stable on medications for at least four weeks, and able to participate in online therapy.
✕Probably not a fit
Patients who have chronic psychosis, bipolar disorder type 1, significant cognitive impairment, severe self-harm behavior, or are engaged in other intensive treatments may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial applies a hybrid dialectical behavior therapy (DBT) approach to veterans with war-related PTSD and emotion regulation difficulties who have not responded fully to prior treatments. Participants are adults treated at the Sinai Center who are stable on medications and able to engage in online components of therapy. The program builds on a prior 12-week VIBU model by adding an aftercare element to reinforce DBT skills in daily life. Therapists use an online platform to deliver DBT modules, homework, and remote communication with patients. The study aims to determine whether this hybrid DBT approach sustains symptom reduction over time.
Why it matters
Potential benefit: If successful, participants may experience reduced PTSD and emotion regulation problems and better ability to manage distress in daily life.
How similar studies have gone: Previous work on VIBU and aftercare DBT has shown symptom reduction, with some recurrence after discharge, suggesting potential benefit from sustained hybrid DBT.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult veteran (18 years or older), treated at Sinai Center, with knowledge of DBT * Primairy diagnosis of PTSD, determined with CAPS-5, resulting from war-related traumas * Stable for four weeks on their medication (type and doses) * Able to to do online homework assignments and communicate with their therapist via an eHealth platform * Dutch speaking Exclusion Criteria: * Chronic psychosis (psychotic features as comorbidity from PTSD is allowed) or bipolar disorder type 1 * IQ below 80 or cognitive disorders * Severe self-harming behaviour, such as auto-mutilation or suicidal ideations as main problem * Following day treatments or other intensive treatment for residual symptoms
Where it's running
-
Sinai Center
Amstelveen, North Holland, Netherlands Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hyperbaric Oxygen Therapy for Veterans With TBI and PCS
This study tests whether 40 HBOT sessions can change blood biomarkers in veterans with traumatic brain injury and persistent symptoms, and whether PTSD affects those biomarker changes.
-
Internet-delivered ACT for youth with PTSD and chronic pain
A small pilot study will test a web-based Acceptance and Commitment Therapy program for teens and young adults with PTSD and chronic pain to see if it helps with symptoms and functioning.
-
Reboxetine plus Ritalin vs Dog-Assisted Therapy for PTSD
This study tests whether a drug combo of reboxetine and methylphenidate works better than dog-assisted therapy for people with PTSD.
-
Floatation-REST for frontline workers with post-traumatic stress symptoms
This early pilot tests whether two 60-minute Floatation-REST sessions can be safely tried by frontline healthcare workers and first responders who have post-traumatic stress symptoms, compared to watching a documentary.
-
Short-Term Intensive PTSD Treatment for Military Personnel
This trial tests whether a brief, massed form of CPT and EMDR can quickly reduce PTSD symptoms and related cognitive problems in active-duty military personnel.
-
Exposure by Assessment: Testing AMQ-based EMA on Intrusive Trauma Memories in PTSD
We’re testing whether daily prompts to focus on a traumatic memory (vs. a neutral memory) using a simple at-home EMA can reduce intrusive PTSD memories and overall PTSD symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.